Literature DB >> 26692929

PGC-1 mediates the regulation of metformin in muscle irisin expression and function.

Zaigang Yang1, Xu Chen1, Yujuan Chen1, Qian Zhao1.   

Abstract

BACKGROUND: Overweight and obesity are rapidly becoming major global health, social, and economic problems. Irisin is a newly termed hormone that is related to metabolic diseases. In the present study, the mechanism underlying the effect of Metformin on promoting irisin release from skeletal muscle was investigated.
METHODS: C57BL/6J-ob/ob was orally administrated with Metformin for 4 weeks. The plasma irisin, insulin, and glucose were detected. Mouse skeletal muscle myoblasts C2C12 cells were treated with Metformin for 24 h. The molecules PGC-1α, FNDC5, AMPK, and ERK mRNA/proteins were quantified by real-time PCR and western blotting in vivo and in vitro.
RESULTS: Metformin elevated FNDC5 mRNA/protein expression of skeletal muscle and plasma irisin concentration in ob/ob mice. PGC-1α, p-AMPK and p-ERK protein expression was up-regulated by Metformin in skeletal muscle and C2C12 cells. In addition, the decrease in irisin concentration and protein expression of FNDC5, p-AMPK, and p-ERK induced by siRNA-PGC-1α could not be reversed by Metformin.
CONCLUSION: Our study demonstrates that Metformin stimulates irisin secretion from skeletal muscle into the circulation system of obese mice, and that PGC-1α is a critical regulator in this process.

Entities:  

Keywords:  FNDC5; Metformin; diabetes; obesity mice

Year:  2015        PMID: 26692929      PMCID: PMC4656762     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  22 in total

1.  Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes.

Authors:  Fabian Sanchis-Gomar; Giuseppe Lippi; Sara Mayero; Carme Perez-Quilis; José L García-Giménez
Journal:  J Diabetes       Date:  2012-09       Impact factor: 4.006

2.  High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects.

Authors:  G Sesti; F Andreozzi; T V Fiorentino; G C Mannino; A Sciacqua; M A Marini; F Perticone
Journal:  Acta Diabetol       Date:  2014-03-12       Impact factor: 4.280

3.  Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation.

Authors:  D-J Li; F Huang; W-J Lu; G-J Jiang; Y-P Deng; F-M Shen
Journal:  Acta Physiol (Oxf)       Date:  2014-11-24       Impact factor: 6.311

4.  Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling.

Authors:  Yuan Zhang; Rui Li; Yan Meng; Shiwu Li; William Donelan; Yan Zhao; Lei Qi; Mingxiang Zhang; Xingli Wang; Taixing Cui; Li-Jun Yang; Dongqi Tang
Journal:  Diabetes       Date:  2013-10-22       Impact factor: 9.461

5.  PPARgamma coactivator-1alpha expression during thyroid hormone- and contractile activity-induced mitochondrial adaptations.

Authors:  Isabella Irrcher; Peter J Adhihetty; Treacey Sheehan; Anna-Maria Joseph; David A Hood
Journal:  Am J Physiol Cell Physiol       Date:  2003-06       Impact factor: 4.249

Review 6.  Metformin revisited: a critical review of the benefit-risk balance in at-risk patients with type 2 diabetes.

Authors:  A J Scheen; N Paquot
Journal:  Diabetes Metab       Date:  2013-03-23       Impact factor: 6.041

7.  Association between irisin and homocysteine in euglycemic and diabetic subjects.

Authors:  Rafael Alis; Fabian Sanchis-Gomar; Helios Pareja-Galeano; Antonio Hernández-Mijares; Marco Romagnoli; Víctor M Víctor; Milagros Rocha
Journal:  Clin Biochem       Date:  2014-09-03       Impact factor: 3.281

8.  Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women.

Authors:  Ana B Crujeiras; María Pardo; Roca-Rivada Arturo; Santiago Navas-Carretero; M Angeles Zulet; J Alfredo Martínez; Felipe F Casanueva
Journal:  Am J Hum Biol       Date:  2013-12-05       Impact factor: 1.937

9.  Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491.

Authors:  Sandrine Horman; Didier Vertommen; Richard Heath; Dietbert Neumann; Véronique Mouton; Angela Woods; Uwe Schlattner; Theo Wallimann; David Carling; Louis Hue; Mark H Rider
Journal:  J Biol Chem       Date:  2005-12-09       Impact factor: 5.157

10.  FNDC5/irisin is not only a myokine but also an adipokine.

Authors:  Arturo Roca-Rivada; Cecilia Castelao; Lucía L Senin; María O Landrove; Javier Baltar; Ana Belén Crujeiras; Luisa María Seoane; Felipe F Casanueva; María Pardo
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

View more
  11 in total

Review 1.  Physiology and role of irisin in glucose homeostasis.

Authors:  Nikolaos Perakakis; Georgios A Triantafyllou; José Manuel Fernández-Real; Joo Young Huh; Kyung Hee Park; Jochen Seufert; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2017-02-17       Impact factor: 43.330

2.  Metformin inhibits development of diabetic retinopathy through inducing alternative splicing of VEGF-A.

Authors:  Quan-Yong Yi; Gang Deng; Nan Chen; Zhi-Sha Bai; Jian-Shu Yuan; Guo-Hai Wu; Yu-Wen Wang; Shan-Jun Wu
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

3.  Pentamethylquercetin Regulates Lipid Metabolism by Modulating Skeletal Muscle-Adipose Tissue Crosstalk in Obese Mice.

Authors:  Jianzhao Wu; Jingxia Du; Zhi Li; Wei He; Min Wang; Manwen Jin; Lei Yang; Hui Liu
Journal:  Pharmaceutics       Date:  2022-05-29       Impact factor: 6.525

4.  FNDC5 expression and circulating irisin levels are modified by diet and hormonal conditions in hypothalamus, adipose tissue and muscle.

Authors:  B M Varela-Rodríguez; L Pena-Bello; P Juiz-Valiña; B Vidal-Bretal; F Cordido; S Sangiao-Alvarellos
Journal:  Sci Rep       Date:  2016-07-19       Impact factor: 4.379

5.  Effect of sitagliptin on expression of skeletal muscle peroxisome proliferator-activated receptor γ coactivator-1α and irisin in a rat model of type 2 diabetes mellitus.

Authors:  Yuntao Liu; Feng Xu; Pan Jiang
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

6.  Antidiabetic Effect of Tibetan Medicine Tang-Kang-Fu-San on High-Fat Diet and Streptozotocin-Induced Type 2 Diabetic Rats.

Authors:  Bailu Duan; Zhongqiu Zhao; Ling Lin; Jing Jin; Lijun Zhang; Hui Xiong; Na Ta; Tiexiang Gao; Zhinan Mei
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-17       Impact factor: 2.629

7.  Antidiabetic Effect of Tibetan Medicine Tang-Kang-Fu-San in db/db Mice via Activation of PI3K/Akt and AMPK Pathways.

Authors:  Bailu Duan; Zhongqiu Zhao; Weifang Liao; Hui Xiong; Sisi Liu; Liang Yin; Tiexiang Gao; Zhinan Mei
Journal:  Front Pharmacol       Date:  2017-08-24       Impact factor: 5.810

8.  Irisin attenuates intestinal injury, oxidative and endoplasmic reticulum stress in mice with L-arginine-induced acute pancreatitis.

Authors:  Yi-Fan Ren; Meng-Zhou Wang; Jian-Bin Bi; Jia Zhang; Lin Zhang; Wu-Ming Liu; Sha-Sha Wei; Yi Lv; Zheng Wu; Rong-Qian Wu
Journal:  World J Gastroenterol       Date:  2019-12-07       Impact factor: 5.742

9.  Serum Irisin Predicts Posthepatectomy Complications in Patients with Hepatocellular Carcinoma.

Authors:  Jia Zhang; Mengyun Ke; Yifan Ren; Jianbin Bi; Zhaoqing Du; Mei Zhang; Yawen Wang; Lin Zhang; Zheng Wu; Yi Lv; Rongqian Wu
Journal:  Dis Markers       Date:  2019-12-28       Impact factor: 3.434

10.  The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.

Authors:  Katarzyna Komosinska-Vassev; Olga Gala; Krystyna Olczyk; Agnieszka Jura-Półtorak; Paweł Olczyk
Journal:  Biomolecules       Date:  2020-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.